Call for Applications for the Emory Training Program in HIV Translational Research to End the Epidemic
TRAINING OPPORTUNITY: Fellow-driven & mentor-supported HIV translational research fellowships at Emory University
Are you a PhD, MD, MD/PhD graduate with an interest in HIV Translational Research? Are you within seven years of your terminal degree? Are you a U.S. Citizen or Naturalized (Green Card) U.S. Citizen? Can you devote two years to training?
All trainees must commit full-time effort to the program and its related research activities.
Eligible Areas of HIV Research
- Laboratory-based science, vaccine, and cure research
- Patient-centered clinical research
- Public health and implementation science
Trainees will gain expertise in cross-cutting areas ofscience and translation to the Ending the HIV Epidemic Initiative
HIV T32 Program Trainees will Receive:
- Annual stipend at appropriate NIH-specifiedlevel based on years of postdoc experience
- Travel & childcare allotments; research supplies
- Tuition support for formal didactic training intranslational research (MSCR, CPTR, or selectedgraduate level courses)
- Hands-on translational research rotation
DEADLINE FOR SUBMISSION: April 15, 2022
1. Potential candidates should complete an HIV T32 Interest Form to initiate discussion with the faculty Program Director (PD) in the target area of interest regarding the candidate application: https://bit.ly/EmoryHIVT32
a. Laboratory-based basic science, vaccine, and cure research: Ann Chahroudi, MD, PhD
b. Patient-centered clinical research: Colleen Kelley, MD, MPH
c. Public health and implementation science: Patrick Sullivan, DVM, PhD
2. Applicants will identify potential mentor(s) from the list below during the discussion with the faculty PD. The PD will then contact the mentor(s) suggested to confirm willingness to meet with the applicant.
3. The Program Coordinator will then connect applicants and potential mentors. It is up to the applicant/mentor to meet and mutually decide the best fit. Once the mentor has agreed to support the trainee throughout the duration of the appointment, the applicant must notify the Program Coordinator via email of final decision.
4. Approval to apply should be obtained prior to April 1, 2022. Candidates are encouraged to apply after mentor and program reviews are
To apply, submit an application package including the following documents as a single PDF via email to email@example.com by 5 PM EST on April 15, 2022:
- Cover letter specifying focus area of interest with statement of future goals for a career in HIV research. Applicants should include personal qualifications for the fellowship and what they hope to gain from the fellowship;
- Current CV or NIH biosketch;
- A letter of support from the proposed HIV T32 mentor;
- Letter(s) of support from one other scientist (e.g. recent supervisor, mentor, or a collaborator);
- A two-page description of the proposed research project and proposed didactic training plan (including graphs/figures but not references);
- MD applicants from clinical departments must also provide a letter from the applicant’s Department/Division Chair, indicating departmental commitment to provide at least 75% protected time for the trainee applicant to devote to the proposed research project. This letter can be same as the required letter of support from one other scientist, described above.